Additionally, we analyzed NELF-E expression by immunohistochemistry on commercial breast cancer tissue microarrays and confirmed a higher protein expression of NELF-E in tumor tissues (grade 1 to 3) compared to normal breast tissue (grade 0) (Supplementary Fig. 3c). This evidence concerns the gene NELFE and breast carcinoma.